期刊文献+

药物洗脱支架治疗冠状动脉疾病疗效优势的研究进展 被引量:2

Research Progress in the Therapeutic Advantages of Drug-eluting Stent Implantation for Coronary Artery Disease
下载PDF
导出
摘要 药物洗脱支架(DES)取代裸金属支架(BMS)应用于临床是心脏病介入治疗领域的突破性进展。DES的介入治疗可与冠状动脉旁路移植术(CABG)媲美,后者是目前临床上治疗冠状动脉疾病的标准方法。DES可较好控制再狭窄率的效果。此外,复杂程度较低的冠心病患者用DES进行经皮冠状动脉介入(PCI)的疗效好。但是CABG依然是左前降支或左主干冠状动脉病以及复杂的多血管病变患者优先选择的治疗方案。 Bare-metal stents have been replaced by drug-during stents( DES), which is considered as a breakthrough therapy that might compete with coronary artery bypass grafting(CABG) as the standard treat- ment for coronary artery disease. DES can control the effect of restenosis rate. In addition,less complex coro- nary heart disease patients treated by percutaneous coronary intervention with DES have better therapeutic effect. However,CABG is still the priority option for patients with left anterior descending coronary artery involvement, left main involvement, or multivessel disease.
出处 《医学综述》 2015年第9期1618-1621,共4页 Medical Recapitulate
关键词 药物洗脱支架 冠状动脉旁路移植术 经皮冠状动脉介入 Drug-eluting stents Coronary artery bypass grafting Percutaneous coronary intervention
  • 相关文献

参考文献53

  • 1Epstein AJ,Polsky D,Yang F,et al.Coronary revascularization trends in the United States,2001-2008[J].JAMA,2011,305(17):1769-1776.
  • 2Head SJ,Bogers AJ,Serruys PW,et al.A crucial factor in shared decision making:the team approach[J].Lancet,2011,377(9708):1836.
  • 3于波.2011年冠心病介入治疗新进展[J].中国医学前沿杂志(电子版),2012,4(2):28-30. 被引量:9
  • 4Morice MC,Serruys PW,Sousa JE,et al.A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization[J].N Engl J Med 2002,346(23):1773-1780.
  • 5Kastrati A,Mehilli J,Pache J,et al.Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents[J].N Engl J Med2007,356(10):1030-1039.
  • 6Stettler C,Wandel S,Allemann S,et al.Outcomes associated with drug-eluting and bare-metal stents:a collaborative network metaanalysis[J].Lancet,2007,370(9591):937-948.
  • 7Grube E,Silber S,Hauptmann KE,et al.TAXUS I:six-and twelvemonth results from a randomized,double-blind trial on a slowrelease paclitaxel-eluting stent for de novo coronary lesions[J].Circulation,2003,107(1):38-42.
  • 8Garg S,Serruys PW.Coronary stents:current status[J].J Am Coll Cardiol,2010,56(10 suppl):S1-42.
  • 9Turco MA,Ormiston JA,Popma JJ,et al.Polymer-based,paclitaxeleluting TAXUS Liberte stent in de novo lesions:the pivotal TAXUS ATLAS trial[J].J Am Coll Cardiol,2007,49(16):1676-1683.
  • 10Kim JW,Seo HS,Park JH,et al.A prospective,randomized,6-month comparison of the coronary vasomotor response associated with a zotarolimus-versus a sirolimus-eluting stent:differential recovery of coronary endothelial dysfunction[J].J Am Coll Cardiol,2009,53(18):1653-1659.

二级参考文献27

  • 1Diegeler A,Thiele H,Falk V,et al.Comparison of stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery[J].N Engl J Med,2002,347:561-566.
  • 2Morice MC,Serruys PW,Sousa JE,et al.A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization[J].N Engl J Med,2002,346:1772-1780.
  • 3Stone GW,Ellis SG,Cox DA,et al.A polymer-based,paclitaxel-eluting stent in patients with coronary artery disease[J].N Engl J Med,2004,350:221-231.
  • 4Cisowski M,Drzewiecki J,Drzewiecka A,et al.Primary stenting versus MIDCAB:preliminary report-comparisco of two methods of revascularization in single left anterior descending coronary artery stenosis[J].Ann Thorac Surg,2002,74:S1334-1339.
  • 5Iakovon I,Dangas G,Mehran R,et al.Minimally invasive direct coronary?artery bypass(MIDCAB)versus coronary artery stenting for elective revascularization of the left anterior descending artery[J].Am J Cardid,2002,92:885-887.
  • 6Shirai K,Lansky AJ,Mehran R,et al.Minimally invasive coronary artery bypass grafting versus stenting for patients with proximal left anterior descending coronary artery disease[J].Am JCardiol,2004,93:959-962.
  • 7Kurbaan AS,BowkerTJ,Rickards AF,et al.Differential restenosis rate of individual coronary artery sites after multivessel angioplasty:implications for revascularization strategy-Coronary Angioplesty versus Bypass Revascularizatico Investigation(CABRI)[J].Am Heart J,1998,135:703-708.
  • 8Ashby DT,Dangas G,Mehran R,et al.Comparison of clinical outcomes using stents versus nestents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteries[J].Am J Cardiol,2002,89:1162-1166.
  • 9Semhney N,Moses JW,Leon MB,et al.Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents[J].Circulation,2004,110:374-379.
  • 10Arampatzis CA,Hoye A,Lemes PA,et al.Elective sirolimus-eluting stent implantation for multivessel disease involving significant LAD stenosis:one-yesr clinical outcomes of 99 consecutive patients-the Rotterdam experience[J].Catheter Cardiovase Inrerv,2004,63:57-60.

共引文献11

同被引文献49

  • 1张广成,孙冰,汪捷猛.药物洗脱支架植入与冠状动脉旁路移植术治疗多支冠状动脉病变临床疗效的对比研究[J].中外医疗,2007(21):1-2. 被引量:2
  • 2薛松.冠状动脉外科进展[J].外科研究与新技术,2014,3(2):92-95. 被引量:3
  • 3徐勤成,孙晓斐,丛培玲,张申,任长杰,郝丽.复杂冠脉病变经皮冠状动脉介入治疗与冠状动脉旁路移植术的临床比较[J].济宁医学院学报,2005,28(2):17-19. 被引量:2
  • 4张天嵩,钟文昭.实用循证医学方法学[M].长沙:中南大学出版社,2012:352—379.
  • 5Gilles Montalescot,Udo Sechtem,Stephan Achenbach,Felicita Andreotti,Chris Arden,Andrzej Budaj,Raffaele Bugiardini,Filippo Crea,Thomas Cuisset,Carlo Di Mario,J. Rafael Ferreira,Bernard J. Gersh,Anselm K. Gitt,Jean-Sebastien Hulot,Nikolaus Marx,Lionel H. Opie,Matthias Pfisterer,Eva Prescott,Frank Ruschitzka,Manel Sabaté,Roxy Senior,David Paul Taggart,Ernst E. van der Wall,Christiaan J.M. Vrints,Jose Luis Zamorano,Stephan Achenbach,Helmut Baumgartner,Jeroen J. Bax,Héctor Bueno,Vero.2013 ESC guidelines on the management of stable coronary artery disease[J]. European Heart Journal . 2013 (38)
  • 6张恒,袁昕,徐波,等.老年急性冠状动不同冠脉再血管化治疗策略对合并糖尿病的多支冠脉病变患者的疗效比较[J].中国循环杂志,2014,29(增刊):87-88.
  • 7Michael S. Lee,Pooya Bokhoor,Seung-Jung Park,Young-Hak Kim,Gregg W. Stone,Imad Sheiban,Giuseppe Biondi-Zoccai,Dario Sillano,Jonathan Tobis,David E. Kandzari.??Unprotected Left Main Coronary Disease and ST-Segment Elevation Myocardial Infarction(J)JACC: Cardiovascular Interventions . 2010 (8)
  • 8Joanna Chikwe,Michael Kim,Andrew B. Goldstone,Arzhang Fallahi,Thanos Athanasiou.??Current diagnosis and management of left main coronary disease(J)European Journal of Cardio-Thoracic Surgery . 2010 (4)
  • 9Coronary Aneurysms After Drug-Eluting Stent Implantation(J)Journal of the American College of Cardiology . 2009 (22)
  • 10Marie-Claude Morice,Patrick W. Serruys,A. Pieter Kappetein,Ted E. Feldman,Elisabeth St?hle,Antonio Colombo,Michael J. Mack,David R. Holmes,James W. Choi,Witold Ruzyllo,Grzegorz Religa,Jian Huang,Kristine Roy,Keith D. Dawkins,Friedrich Mohr.??Five-Year Outcomes in Patients With Left Main Disease Treated With Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Trial(J)Circulation . 2014 (23)

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部